Dimopoulos MA

No ORCID on file · 4 papers in corpus · active 2009-2025
2025
Biomedicines ·doi:10.3390/biomedicines13112820

Ovarian cancer is the gynecologic malignancy that bears the highest mortality rate in the Western world. This is attributed to late diagnosis and limited therapeutic progress. Recent advances in molecular oncology have highlighted the pivot…

2025
Current oncology (Toronto, Ont.) ·doi:10.3390/curroncol32050251

Uterine serous carcinomas are an aggressive minority of endometrial cancers. They are characterized by mutations in TP53 and extensive copy number alterations and are primarily classified in the copy number-high/p53abn molecular prognostic …

2022
Frontiers in oncology ·doi:10.3389/fonc.2022.1030786

BackgroundGermline BRCA1/2 mutations are identified in 13-15% of ovarian cancers, while an additional 5-7% of ovarian cancers harbor somatic BRCA1/2 mutations. Beyond these mutations, germline or somatic aberrations in genes of the homologo…

2009
World journal of surgical oncology ·doi:10.1186/1477-7819-7-38

Uterine sarcomas are a rare group of neoplasms with aggressive clinical course and poor prognosis. They are classified into four main histological subtypes in order of decreasing incidence: carcinosarcomas, leiomyosarcomas, endometrial stro…